LEADER 00966nam1-22002891i-450- 001 990000113460403321 035 $a000011346 035 $aFED01000011346 035 $a(Aleph)000011346FED01 035 $a000011346 100 $a20011111d--------km-y0itay50------ba 101 0 $aita 105 $ay-------001yy 200 1 $aGrandi utilizzazioni idrauliche per forza motrice$eelenco degli impianti in funzione e in costruzione$fMinistero deilavori pubblici. Consiglio superiore. Servizio idrografico. 210 $aRoma$cIstituto poligrafico dello Stato$d1934- 215 $av. 24 cm 225 1 $aPubblicazione del Servizio idrografico$v10 610 0 $aImpianti idroelettrici 676 $a621.312 134 710 02$aServizio idrografico$0289889 801 0$aIT$bUNINA$gRICA$2UNIMARC 901 $aBK 912 $a990000113460403321 959 $aFINBC 996 $aGrandi utilizzazioni idrauliche per forza motrice$9115391 997 $aUNINA DB $aING01 LEADER 02424nam 2200577Ia 450 001 9910464604403321 005 20200520144314.0 010 $a1-282-41487-9 010 $a9786612414879 010 $a1-4438-1604-3 035 $a(CKB)3390000000009034 035 $a(EBL)1133152 035 $a(OCoLC)830167710 035 $a(SSID)ssj0000852483 035 $a(PQKBManifestationID)11453275 035 $a(PQKBTitleCode)TC0000852483 035 $a(PQKBWorkID)10852703 035 $a(PQKB)10614698 035 $a(MiAaPQ)EBC1133152 035 $a(Au-PeEL)EBL1133152 035 $a(CaPaEBR)ebr10677111 035 $a(CaONFJC)MIL241487 035 $a(EXLCZ)993390000000009034 100 $a20090923d2009 uy 0 101 0 $aeng 135 $aur|n|---||||| 181 $ctxt 182 $cc 183 $acr 200 00$a21st century China$b[electronic resource] $eviews from Australia /$fedited by Mary Farquhar 210 $aNewcastle $cCambridge Scholars$dc2009 215 $a1 online resource (260 p.) 300 $aDescription based upon print version of record. 311 $a1-4438-1259-5 327 $aTABLE OF CONTENTS; FIGURES; ILLUSTRATIONS; RECIPES; TABLES; INTRODUCTION; CHAPTER ONE; CHAPTER TWO; CHAPTER THREE; CHAPTER FOUR; CHAPTER FIVE; CHAPTER SIX; CHAPTER SEVEN; CHAPTER EIGHT; CHAPTER NINE; CHAPTER TEN; CHAPTER ELEVEN; CHAPTER TWELVE; CONTRIBUTORS 330 $aAustralia's Prime Minister Kevin Rudd famously said that China issues are part of 21st century Australia's 'very life-blood'. This brings short-term challenges to the Australia-China relationship, from Chinese investments in our resources to visits to Australia by expatriate regional political and religious leaders, labelled 'splittists' or 'terrorists', by the Chinese government. Our long-term relationship includes robust scholarship on China as an emerging superpower. In this book, leading ... 606 $aSocial change$zChina$y21st century 607 $aAustralia$xRelations$zChina 607 $aChina$xEconomic conditions$y2000- 607 $aChina$xSocial conditions$y2000- 608 $aElectronic books. 615 0$aSocial change 676 $a951.058 701 $aFarquhar$b Mary Ann$f1949-$0971718 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910464604403321 996 $a21st century China$92209272 997 $aUNINA LEADER 03460nam 2200493 450 001 9910717370003321 005 20221025090050.0 035 $a(CKB)2670000000429551 035 $a(NjHacI)992670000000429551 035 $a(OCoLC)815716442$z(OCoLC)810458985 035 $a(EXLCZ)992670000000429551 100 $a20221025d2012 uy 0 101 0 $aeng 135 $aur||||||||||| 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 00$aUse of left ventricular assist devices as destination therapy in end-stage congestive heart failure $ea systematic review /$f[investigators, Thomas S. Rector [and four others]] 210 1$aWashington, D.C. :$cDept. of Veterans Affairs, Health Services Research & Development Service,$d[2012] 210 4$dİ2012 215 $a1 online resource (iii, 41 pages) $cillustrations 225 1 $aEvidence-based Synthesis Program 300 $a"Evidence-based synthesis program." 300 $a"May 2012." 320 $aIncludes bibliographical references. 330 3 $aHeart failure is defined as reduced ability of the heart to pump blood and maintain normal bodily function. Heart transplantation is currently the preferred treatment for end-stage heart failure but the supply of donor hearts is insufficient to meet the need and many patients are not eligible for transplantation due to age or comorbid conditions. Implantable mechanical pumps can assist the circulation of blood by the ventricles. Left ventricular assist devices (LVADs) have been approved by the U.S. Food and Drug Administration (FDA) for use in patients awaiting transplant (a bridge to transplant) and as a last resort in patients with refractory heart failure who are not eligible for a heart transplant (destination therapy). In January 2010, the first newer generation, rotary continuous flow ventricular assist device (HeartMate II) was approved by the FDA for destination therapy. Eligibility criteria are essentially the same as those used to select patients for the pivotal clinical trial that included patients with shortness of breath and/or fatigue at rest or during minimal exertion despite treatment with optimal therapy for heart failure associated with a low ejection fraction (<25%) who were not candidates for heart transplantation due to their age or co-morbid conditions. The purpose of this report is to review the scientific evidence for use of the current generation of left ventricular assist devices as destination therapy. 410 0$aEvidence-based synthesis program (Series) 517 $aUse of left ventricular assist devices as destination therapy in end-stage congestive heart failure 606 $aHeart, Mechanical 607 $aUnited States$2fast 615 0$aHeart, Mechanical. 676 $a617.4120592 700 $aRector$b Thomas S.$0189497 702 $aRector$b Thomas S. 712 02$aQuality Enhancement Research Initiative (U.S.) 712 02$aUnited States.$bDepartment of Veterans Affairs.$bHealth Services Research and Development Service, 712 02$aMinneapolis VA Health Care System (U.S.).$bVA Evidence Synthesis Program. 712 02$aEvidence-based Synthesis Program (U.S.) 801 0$bNjHacI 801 1$bNjHacl 906 $aBOOK 912 $a9910717370003321 996 $aUse of left ventricular assist devices as destination therapy in end-stage congestive heart failure$93463910 997 $aUNINA